How to cite item

The importance of antiandrogen in prostate cancer treatment

   
@article{ATM30118,
	author = {Camille Lanz and Mostefa Bennamoun and Petr Macek and Xavier Cathelineau and Rafael Sanchez-Salas},
	title = {The importance of antiandrogen in prostate cancer treatment},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {Suppl 8},
	year = {2019},
	keywords = {},
	abstract = {Since 2011, Docetaxel is no longer the exclusive treatment for castration-resistant prostate cancer (CRPC), with the emergence of a new generation of hormonal treatments  (1-4). Although the first antiandrogens generation has shown clinical benefit, their low affinity for the androgen receptor (AR) allows for the 5% to 10% of free dihydrotestosterone in the prostate to activate the AR (1).},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/30118}
}